Viva Biotech Holdings (1873.HK) HKSE
1.68
-0.04(-2.33%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.68
-0.04(-2.33%)
Currency In HKD
| Market Cap | 3.41B |
| Enterprise Value | 3.63B |
| P/E Ratio | 6.38 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 1.8 |
| Price/Book Ratio | 0.35 |
| Enterprise/Revenue | 1.93 |
| Enterprise/EBITDA | 8.43 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.13 |
| Operating Margin | 0.11 |
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
| Revenue | 1.68B |
| Revenue/Share | 1.8 |
| Gross Profit | 638.59M |
| EBITDA | 393.84M |
| Net Income | 214.07M |
| Diluted EPS | 0.09 |
| Total Cash | 1.13B |
| Total Cash/Share | 1.19 |
| Total Debt | 1.33B |
| Total Debt/Equity | 0.33 |
| Current Ratio | 1.5 |
| Book Value Per Share | 4.22 |
| 52-Week Change | 11.26 |
| 52-Week High | 3.27 |
| 52-Week Low | 1.34 |
| Moving Average 50 Days | 2.08 |
| Moving Average 200 Days | 2.17 |
| Average Volume | 9.04M |
| Shares Outstanding | 2.11B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |